AI assistant
Sending…
EXOZYMES INC. — Director's Dealing 2024
Nov 20, 2024
34055_dirs_2024-11-19_3fde3cc9-4ee5-435c-863d-78b3ccf47dc1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-15
Reporting Person: Heltzen Michael (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-15 | Common Stock | P | 1984 | $11.10 | Acquired | 1984 | Direct |
More from EXOZYMES INC.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Feb 5
Capital/Financing Update
2026
Jan 26
Regulatory Filings
2026
Jan 26
Capital/Financing Update
2026
Jan 16